ASHIKAG vs NIVABUPA: Stock Comparison

ASHIKAG vs NIVA BUPA HEALTH INS CO LUpdated 10 Aug 26, 4:08 PM ISTNSE & company filings

NIVA BUPA HEALTH INS CO L is the larger company by market capitalisation. ASHIKAG shows a lower P/E, while NIVA BUPA HEALTH INS CO L shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ASHIKAG leads 3; NIVABUPA leads 3 of 7

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ASHIKAGNIVABUPA

Valuation lens

What price are you paying?

Market CapContext only
₹2,956 Cr
₹14,923 Cr
P/E RatioASHIKAG has the lower reading
0x
116.18x
P/B RatioASHIKAG has the lower reading
0x
4x
EPSASHIKAG has the higher reading
₹12.27
₹1.87
Book ValueContext only
₹158.15
₹23.73
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
NIVABUPA is the larger company
₹14,923 Cr vs ₹2,956 Cr
P/E Ratio
ASHIKAG has a lower P/E
0x vs 116.18x
P/B Ratio
ASHIKAG has a lower P/B
0x vs 4x
EPS
ASHIKAG has higher earnings per share
₹12.27 vs ₹1.87
Revenue Growth (TTM YoY)
NIVABUPA has faster revenue growth
26.8% vs 0%
EPS Growth (TTM YoY)
NIVABUPA has faster EPS growth
90.2% vs 0%
Net Margin
NIVABUPA has a higher net margin
4.34% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricASHIKAGNIVABUPA
SectorFinancial Services
IndustryGeneral Insurance

Price

MetricASHIKAGNIVABUPA
Live Price₹427.45₹80.73
Day Change-5.93%-1.91%
Volume3.51 L3.66 L
52-Week High₹520.95₹91.4
52-Week Low₹396.2₹67.5
Distance from 52W High-17.95%-11.67%

Valuation

MetricASHIKAGNIVABUPA
Market Cap₹2,956 Cr₹14,923 Cr
P/E Ratio0x116.18x
P/B Ratio0x4x
EPS₹12.27₹1.87
Book Value₹158.15₹23.73
Dividend Yield0%0%

Growth

MetricASHIKAGNIVABUPA
Revenue Growth (TTM YoY)0%26.8%
EPS Growth (TTM YoY)0%90.2%
Qtr Sales Growth-26.36%
Qtr Profit Growth-10.15%

Profitability & Leverage

Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.
MetricASHIKAGNIVABUPA
ROE0%
ROCE0%
Net Margin0%4.34%
Debt to Equity0.07x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricASHIKAGNIVABUPA
Promoter Holding74.31% 16.32 pp0%
FII Holding1.45% 0.72 pp12.09% 1.49 pp
DII Holding0.44% 0.29 pp16.17% 0.32 pp
Public Holding23.79% 16.76 pp16.44% 1.11 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ASHIKAG and NIVA BUPA HEALTH INS CO L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.